Intelomed, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2016 | $2 M | No. 4 | Under $2 million | equity | SEC | |
| Jul 2014 | $4 M | No. 3 | $2 to $10 million | equity | SEC | |
| Sep 2013 | $2 M | No. 2 | $2 to $10 million | equity | SEC | |
| May 2011 | $3 M | No. 1 | $2 to $10 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Intelomed, Inc. reported revenue of $33,203 for its most recent fiscal year (filed Oct 2022), up from $14,150 the year before.
SEC Form C · Oct 2022
The direct cost of what it sold was $3,752, so 89% of its revenue was left after those costs.
SEC Form C · Oct 2022
Net loss for the same year: $1.27 million.
SEC Form C · Oct 2022
Intelomed, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2016).
SEC Form D · Jan 2016
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2016
Products and services#
No products or services on record: the address on record now leads to another company's site.
Investors#
No investor of Intelomed, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 29 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jan Berkow | Executive officer | Jan 2016 |
| Jill F. Schiaparelli | Executive officer | Jan 2016 |
| Michael Stephen Dignazio | Executive officer | Jan 2016 |
| Frank J Amoruso | Executive officer | Jul 2014 |
| Mary Del Brady | Executive officer | May 2011 |
| Jan Berkow | Director | Jan 2016 |
| Jill F. Schiaparelli | Director | Jan 2016 |
| Mark P. Rossi | Director | Jan 2016 |
| Mary Del Brady | Director | Jan 2016 |
| R. Stephen Doyle | Director | Jan 2016 |
| William P. Malloy | Director | Jan 2016 |
| Frank J Amoruso | Director | Jul 2014 |
| James Sweeney | Director | Jul 2014 |
| John Moran | Director | Jul 2014 |
| MaryDel Brady | Director | Jul 2014 |
| Jan Berkow | Promoter | Jul 2014 |